Skip to main content

Akeega

Pronunciation: a kee' gah
Generic name: niraparib and abiraterone acetate
Dosage form: tablets (50mg niraparib/500 mg abiraterone acetate, 100 mg niraparib/500 mg abiraterone acetate)
Drug class: Antineoplastic combinations

Medically reviewed by Melisa Puckey, BPharm. Last updated on Aug 14, 2023.

What is Akeega?

Akeega is a prescription medicine used to treat types of prostate cancer, it is used together with prednisone. Akeega contains niraparib and abiraterone acetate and is the first dual-action tablet combining a PARP inhibitor with abiraterone acetate.

Akeega is used for metastatic castration-resistant prostate cancer (mCRPC), that has an abnormal BRCA gene (BRCA-positive). This is prostate cancer that has spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone. Your doctor will perform a test to make sure this medicine right for you.

Akeega received FDA approval on 11 August, 2023, approval was based on positive results from the randomized, double-blind, placebo-controlled multi-center Phase 3 MAGNITUDE study.

How does Akeega work?

Akeega works by slowing prostate cancer cells' ability to grow and by causing prostate cancer cells to die. Akeega contains two active ingredients niraparib, a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor, and abiraterone acetate, an androgen biosynthesis inhibitor. 

Niraparib blocks a protein called PARP, which usually repairs cancer cells to make cancer cells live longer. As niraparib blocks PARP from repairing cancer cells, the cancer cells die.

Abiraterone acetate is an androgen biosynthesis inhibitor. Prostate cancer needs testosterone (male hormone) to grow. Abiraterone works by blocking the body from making testosterone, which can help slow down the growth of the cancer.

Akeega side effects

The most common Akeega side effects: 

Akeega may cause serious side effects 

Bone marrow problems called myelodysplastic syndrome (MDS) or a type of cancer of the blood called acute myeloid leukemia (AML).  See 'Important Information below for more details.

Low blood potassium levels (hypokalemia), fluid retention (edema), high blood pressure (hypertension) and heart problems. Tell your healthcare provider if you have any of the following symptoms 

Liver problems. Severe liver problems, liver failure, and death has happened in people treated with abiraterone acetate, one of the active ingredients in Akeega. Tell your healthcare provider right away if you develop any symptoms of liver problems, including:

Adrenal problems. Adrenal problems may happen if you stop taking prednisone, get an infection, or are under stress. Tell your healthcare provider right away if you develop any symptoms of adrenal problems, including:

Low blood sugar (hypoglycemia). Akeega may cause low blood sugar in people taking medicines for diabetes. Severe low blood sugar has happened in people who take certain medicines for diabetes and were treated with abiraterone acetate, one of the active ingredients in Akeega. You and your healthcare provider should check your blood sugar levels during treatment and after you stop treatment with Akeega. Your healthcare provider may need to change the dose of your diabetes medicine to reduce your risk of low blood sugar. Tell your healthcare provider right away if you have any of the following signs or symptoms of low blood sugar, including:

Increased risk of bone fracture and death when abiraterone acetate, one of the active ingredient in this medicine, and prednisone or prednisolone is used in combination with a type of radiation called Radium 223 (Ra-223) dichloride. You should not receive treatment with Ra-223 dichloride for at least 5 days after your last dose of Akeega with prednisone. Tell your healthcare provider about any other treatments you are taking for prostate cancer.  

Posterior Reversible Encephalopathy Syndrome (PRES). PRES is a condition that affects the brain and may happen during treatment with Akeega. If you have headache, vision changes, confusion, or seizure with or without high blood pressure, please contact your healthcare provider. 

Fertility problems in males this medicine may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility. 

These are not all the possible side effects of Akeega. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Important Information

Akeega may cause serious side effects including:

Bone marrow problems called myelodysplastic syndrome (MDS) or a type of cancer of the blood called acute myeloid leukemia (AML). MDS or AML that may lead to death has happened in people treated with niraparib, one of the active ingredients in Akeega. If you develop MDS or AML, your healthcare provider will stop treatment with this medicine. Symptoms of low blood cell counts (low red blood cells, low white blood cells, and low platelets) are common during treatment with Akeega but can also be a sign of serious bone marrow problems, including MDS and AML. Tell your healthcare provider if you have any of the following symptoms during treatment:

Your healthcare provider will do blood tests to check your blood cell counts: 

What should I tell my doctor before taking Akeega?

Tell your healthcare provider about all of your medical conditions, including if you:

Pregnancy

Females: Tell your healthcare professional if you are pregnant, become pregnant or plan to become pregnant. Akeega can cause harm to your unborn baby and loss of pregnancy (miscarriage).

Females who are or may become pregnant should handle Akeega tablets with protection, such as gloves.

Males: with female partners who are able to become pregnant should use effective birth control (contraception) during treatment and for 4 months after the last dose of this medicine.

Akeega may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility. 

Breastfeeding

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if Akeega passes into your breastmilk.

How should I take Akeega?

Take Akeega exactly as your healthcare provider tells you. 

If you miss a dose of  your tablets, take the dose as soon as possible on the same day. Return to your normal schedule on the following day. Do not take extra tablets to make up the missed dose. 

Akeega Dosing Information

The recommended adult dosage of Akeega is 200 mg niraparib/1,000 mg abiraterone acetate orally once daily in combination with 10 mg prednisone daily until disease progression or unacceptable toxicity. 

Akeega is available as: 

Interactions

Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use. Tell your doctor about all your current medicines and any medicine you start or stop using.

You should not take the group of medicines called strong CYP3A4 inducers with Akeega. Examples of strong CYP3A4 inducers including apalutamide, carbamazepine, enzalutamide, ivosidenib, lumacaftor and ivacaftor, mitotane, phenytoin, rifampin, and St. John’s wort. 

You should not take the group of medicines called CYP2D6 Substrates with Akeega, if a small change in concentration of your medicine may lead to serious toxicities. If alternative treatments cannot be used, consider a dose reduction of the concomitant CYP2D6 substrate. 

Not all possible interactions are listed here. 

Ingredients

Active ingredients: niraparib tosylate and abiraterone acetate. 

Inactive ingredients: 

Core tablet: colloidal anhydrous silica, crospovidone, hypromellose, lactose monohydrate, magnesium stearate, silicified microcrystalline cellulose, sodium lauryl sulfate. 

Film-coating of 50 mg/500 mg tablets: iron oxide black, iron oxide red, iron oxide yellow, sodium lauryl sulphate, glycerol monocaprylocaprate, polyvinyl alcohol, talc, and titanium dioxide. 

Film-coating of 100 mg/500 mg tablets: iron oxide red, iron oxide yellow, sodium lauryl sulphate, glycerol monocaprylocaprate, polyvinyl alcohol, talc, and titanium dioxide.

Storage

Store between 68°F to 77°F (20°C to 25°C).

Company

Manufactured for: Janssen Biotech, Inc., Horsham, PA 19044, USA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.